Insulin aspart, recombinant Subcutaneous and Vectical
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Vectical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: calcitriol topical
Brand name: Vectical
Synonyms: Vectical Ointment
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Vecuronium
- Insulin aspart, recombinant Subcutaneous-Vecuronium Bromide
- Insulin aspart, recombinant Subcutaneous-Vedolizumab
- Insulin aspart, recombinant Subcutaneous-Vedolizumab Intravenous
- Insulin aspart, recombinant Subcutaneous-Veetids
- Insulin aspart, recombinant Subcutaneous-Veetids (Penicillin V Potassium Oral Solution)
- Vectical-Insulin degludec
- Vectical-Insulin Degludec (U-100) Prefilled Pens
- Vectical-Insulin Degludec (U-100) Vials
- Vectical-Insulin Degludec (U-200) Prefilled Pens
- Vectical-Insulin degludec and liraglutide
- Vectical-Insulin degludec and liraglutide Subcutaneous